These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30395647)

  • 1. HEXIM1-Tat chimera inhibits HIV-1 replication.
    Leoz M; Kukanja P; Luo Z; Huang F; Cary DC; Peterlin BM; Fujinaga K
    PLoS Pathog; 2018 Nov; 14(11):e1007402. PubMed ID: 30395647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human immunodeficiency virus type 1 Tat-like arginine-rich RNA-binding domain is essential for HEXIM1 to inhibit RNA polymerase II transcription through 7SK snRNA-mediated inactivation of P-TEFb.
    Yik JH; Chen R; Pezda AC; Samford CS; Zhou Q
    Mol Cell Biol; 2004 Jun; 24(12):5094-105. PubMed ID: 15169877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition step during assembly of HIV Tat:P-TEFb transcription complexes and transfer to TAR RNA.
    D'Orso I; Jang GM; Pastuszak AW; Faust TB; Quezada E; Booth DS; Frankel AD
    Mol Cell Biol; 2012 Dec; 32(23):4780-93. PubMed ID: 23007159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling cellular P-TEFb activity by the HIV-1 transcriptional transactivator Tat.
    Muniz L; Egloff S; Ughy B; Jády BE; Kiss T
    PLoS Pathog; 2010 Oct; 6(10):e1001152. PubMed ID: 20976203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGA1 directly interacts with TAR to modulate basal and Tat-dependent HIV transcription.
    Eilebrecht S; Wilhelm E; Benecke BJ; Bell B; Benecke AG
    RNA Biol; 2013 Mar; 10(3):436-44. PubMed ID: 23392246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent HIV-1 TAR Regulates 7SK-responsive P-TEFb Target Genes and Targets Cellular Immune Responses in the Absence of Tat.
    Eilebrecht S; Benecke BJ; Benecke AG
    Genomics Proteomics Bioinformatics; 2017 Oct; 15(5):313-323. PubMed ID: 29037489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR.
    Sedore SC; Byers SA; Biglione S; Price JP; Maury WJ; Price DH
    Nucleic Acids Res; 2007; 35(13):4347-58. PubMed ID: 17576689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of HEXIM1 at Tyr271 and Tyr274 Promotes Release of P-TEFb from the 7SK snRNP Complex and Enhances Proviral HIV Gene Expression.
    Mbonye UR; Wang B; Gokulrangan G; Chance MR; Karn J
    Proteomics; 2015 Jun; 15(12):2078-86. PubMed ID: 25900325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription.
    Barboric M; Yik JH; Czudnochowski N; Yang Z; Chen R; Contreras X; Geyer M; Matija Peterlin B; Zhou Q
    Nucleic Acids Res; 2007; 35(6):2003-12. PubMed ID: 17341462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat.
    Liang T; Zhang Q; Wu Z; Chen P; Huang Y; Liu S; Li L
    mBio; 2021 Aug; 12(4):e0162521. PubMed ID: 34465029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single point mutation in cyclin T1 eliminates binding to Hexim1, Cdk9 and RNA but not to AFF4 and enforces repression of HIV transcription.
    Kuzmina A; Verstraete N; Galker S; Maatook M; Bensaude O; Taube R
    Retrovirology; 2014 Jul; 11():51. PubMed ID: 24985467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.
    Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D
    mBio; 2016 Jul; 7(4):. PubMed ID: 27381288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDX5 potentiates HIV-1 transcription as a co-factor of Tat.
    Sithole N; Williams CA; Abbink TEM; Lever AML
    Retrovirology; 2020 Mar; 17(1):6. PubMed ID: 32228614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of a human cyclin T1 mutant reveals a different binding surface for Tat and HEXIM1.
    Kuzmina A; Hadad U; Fujinaga K; Taube R
    Virology; 2012 May; 426(2):152-61. PubMed ID: 22342181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure.
    Jin H; Li D; Lin MH; Li L; Harrich D
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32276443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV Tat/P-TEFb Interaction: A Potential Target for Novel Anti-HIV Therapies.
    Asamitsu K; Fujinaga K; Okamoto T
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29673219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZASC1 stimulates HIV-1 transcription elongation by recruiting P-TEFb and TAT to the LTR promoter.
    Bruce JW; Reddington R; Mathieu E; Bracken M; Young JA; Ahlquist P
    PLoS Pathog; 2013 Oct; 9(10):e1003712. PubMed ID: 24204263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK.
    Krueger BJ; Varzavand K; Cooper JJ; Price DH
    PLoS One; 2010 Aug; 5(8):e12335. PubMed ID: 20808803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency.
    Kyei GB; Meng S; Ramani R; Niu A; Lagisetti C; Webb TR; Ratner L
    mBio; 2018 Nov; 9(6):. PubMed ID: 30401776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
    Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.